| Name | Title | Contact Details |
|---|
Internet Blueprint is a Tustin, CA-based company in the Computers and Electronics sector.
Futura Healthcare Technology is a Fort Washington, PA-based company in the Computers and Electronics sector.
Invario Network Engineers is a Arlington, VA-based company in the Computers and Electronics sector.
In 2019 Marlowe Companies Inc. (MCI) was named by Inc. Magazine as Iowa`s Fastest Growing Company in the State of Iowa and was named the 452nd Fastest Growing Privately Company in the USA, making the coveted top 500 for the first time. MCI`s subsidiaries had previously made Inc. Magazine`s List of Fastest Growing Companies 15 times respectively. MCI is headquartered in Iowa City, IA, and has nine customer contact management centers and business processing outsourcing service delivery facilities in Iowa, Georgia, Florida, Massachusetts, New Hampshire, Nova Scotia, and South Dakota. Driving modernization through digitalization, MCI ensures clients do more for less. MCI is the holding company for a diverse lineup of tech-enabled business services operating companies. MCI organically grows, acquires and operates companies that have a synergistic products and services portfolios, including but not limited to business process outsourcing (BPO), business process management (BPM), Customer Experience (CX), Digital Experience (DXP) services, application software, and technology services to mid-market & enterprise partners. MCI now employs 2,500+ talented individuals with 150+ diverse North American client partners across the following MCI brands: GravisApps, Mass Markets, The Sydney Call Centre, OnBrand24, and Valor Intelligent Processing.
We solve healthcare`s matching problem. We provide technology, services, and solutions that precisely match health interventions to individuals, helping our clients improve health outcomes and avoid the billions of healthcare dollars wasted on ineffective treatments. By making the precise matching of interventions to individuals possible, we create data-driven evidence to define what works for whom and puts that knowledge within reach for health plans, health systems, biopharmaceutical companies, and foundations and researchers who are working toward improving health outcomes, patient by patient.